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  (9p24.1) and the IL33 receptor (  2q12) have been reproducibly identified as asthma susceptibility genes. However,Rationale: IL33 IL1RL1,
the variants driving genetic associations are not yet fully defined. Using a population based birth cohort of 1059 children (Manchester
Asthma and Allergy Study-(MAAS)) and 2536 adults with asthma (Genetics of Asthma Severity and Phenotypes - (GASP)) cohort we aimed
to define genetic variants associated with clinical and immunological features of asthma.
 MAAS samples were genotyped using the Illumina 610 Quad array and imputed using 1000G reference panel. GASP samplesMethods:
were genotyped using two custom designed Affymetrix arrays (UK BiLEVE/UK Biobank array). Datasets were quality controlled for gender
mismatches, outliers and relatedness. Data was generated for the  regions consisting of the genes and surrounding regionsIL33/IL1RL1
(chr9:5715785−6757983 & chr2:102427961−103468497) on the following traits: asthma diagnosis (MAAS), atopy, FEV  (GASP) and FEV1 1
/FVC (MAAS and GASP) as well as total blood eosinophil counts and serum total IgE levels (GASP). Variables for blood eosinophils and total
IgE were log10 transformed. Analysis was carried out in PLINK using linear or logistic regression modelling including appropriate
covariates for each trait.
 In the MAAS cohort, we replicated the association of the  locus with asthma diagnosis, identifying potentially twoResults: IL33
independent novel signals in that locus (rs10975398; =1.70E-05; B= -1.519; MAF=0.32 and rs2890697; 1.10E-04; B= -1.573; MAF=0.43).P P=
This association survived a Bonferroni correction for multiple testing. Although not surviving correction, an association was also identified
for atopy in the  locus for MAAS ( =1.08E-04; MAF=0.48). In GASP we identified modest associations not in known LD with publishedIL1RL1 P
loci ( -value range: 5.00E-02 – 7.60E-04) for FEV , FEV /FVC, atopy, blood eosinophils and total IgE in both the  and  loci.P 1 1 IL33 IL1RL1
Multiple SNPs presented nominal association ( <0.01) with more than one trait such as atopy & total IgE, providing supporting evidenceP
for association.
 We replicated the association of  region SNPs with asthma diagnosis in MAAS, highlighting the role of this locus inConclusion: IL33
childhood asthma. Although trait association signals did not survive correction for multiple testing, nominal association across multiple
phenotypes in GASP provides suggestive evidence of the role of the  genetic polymorphisms in determining clinical andIL33/IL1RL1
immunological features of asthma.
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